Analysen von James Quigley

31.03.26 Novartis Sell Goldman Sachs Group Inc.
20.03.26 Novartis Sell Goldman Sachs Group Inc.
04.02.26 Novartis Sell Goldman Sachs Group Inc.
21.01.26 Novartis Sell Goldman Sachs Group Inc.
11.12.25 Roche Sell Goldman Sachs Group Inc.
07.10.25 Roche Sell Goldman Sachs Group Inc.
12.09.25 Novartis Sell Goldman Sachs Group Inc.
29.07.25 Roche Sell Goldman Sachs Group Inc.
04.07.25 Roche Sell Goldman Sachs Group Inc.
10.02.25 Roche Sell Goldman Sachs Group Inc.
06.02.25 Roche Sell Goldman Sachs Group Inc.
30.01.25 Roche Sell Goldman Sachs Group Inc.
14.01.25 Roche Sell Goldman Sachs Group Inc.
19.12.24 Roche Sell Goldman Sachs Group Inc.
26.11.24 Roche Sell Goldman Sachs Group Inc.
03.10.24 Roche Sell Goldman Sachs Group Inc.
26.09.24 Roche Sell Goldman Sachs Group Inc.
16.09.24 Roche Sell Goldman Sachs Group Inc.
12.09.24 Roche Sell Goldman Sachs Group Inc.
10.09.24 Roche Sell Goldman Sachs Group Inc.
25.07.24 Roche Sell Goldman Sachs Group Inc.
17.07.24 Roche Sell Goldman Sachs Group Inc.
15.07.24 Roche Sell Goldman Sachs Group Inc.
04.07.24 Roche Sell Goldman Sachs Group Inc.
02.07.24 Roche Sell Goldman Sachs Group Inc.
17.06.24 Roche Sell Goldman Sachs Group Inc.
03.06.24 Roche Sell Goldman Sachs Group Inc.
30.05.24 Roche Sell Goldman Sachs Group Inc.
06.01.23 MorphoSys Underweight Morgan Stanley
10.08.22 EVOTEC Underweight Morgan Stanley